GLAZER CAPITAL, LLC
Q4 2025 13F-HR Holdings
Net value change ($000)
+824,257
(27.7%)
New positions
120
Sold out positions
69
Turnover %
101.5%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| DAY | 274,220 | 701.1% |
| RNAM | 177,955 | NEW |
| EXAS | 175,191 | NEW |
| CMA | 150,688 | NEW |
| AL | 143,752 | 1265.3% |
| CDTX | 143,621 | NEW |
| BHF | 113,252 | NEW |
| EA | 87,357 | 540.0% |
| CADE | 83,955 | NEW |
| CWAN | 75,846 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| VRNA | -342,099 | -100.0% |
| Merus N.V. | -152,464 | -100.0% |
| COOP | -122,936 | -100.0% |
| AVDX | -85,060 | -100.0% |
| 89bio, Inc. | -82,863 | -100.0% |
| VBTX | -75,288 | -100.0% |
| WNS | -73,913 | -100.0% |
| VTY | -63,188 | -100.0% |
| PHLT | -52,231 | -100.0% |
| ZIMV | -43,456 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
566
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|